Intelligent Bio SolutionsINBS
13F holders, Q2 2026 (June 30)8holders −1
1new positions
2sold out
$2.29avg. 13F price*
At the end of Q2 2026, 8 institutions reported holding Intelligent Bio Solutions Inc. (INBS) in their 13F filings, down 1 from Q1 2026. 1 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($325K), Geode Capital Management, LLC ($48K) and Vanguard Capital Management LLC ($13K).
- Company
- Intelligent Bio Solutions Inc.
- CUSIP
- 36151G709
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $326 |
| Exits | 2 | $128K |
All 13F filers, Q1 2026 → Q2 2026: 18,932 shares bought and 45,925 shares sold, net −26,993 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.01% | Add +8.8% | 141,397 | $325K |
| Geode Capital Management, LLC | 0.00% | Reduce -27.2% | 20,840 | $48K |
| Vanguard Capital Management LLC | 0.00% | No change | 5,810 | $13K |
| UBS Group AG | 0.00% | Add +1441.7% | 5,735 | $13K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 3,958 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +162.4% | 3,280 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $460 |
| Barclays PLC | 0.00% | New | 142 | $326 |
"% of holder's portfolio" is INBS's weight in each manager's 13F, not the share of Intelligent Bio Solutions Inc. the manager owns.